Business Description
Arno Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US0425642032
Description
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 98.86 | |||||
6-1 Month Momentum % | 200 | |||||
12-1 Month Momentum % | 200 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ARNI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arno Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.43 | ||
Beta | -2.43 | ||
Volatility % | 405.6 | ||
14-Day RSI | 98.86 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.0003 | ||
12-1 Month Momentum % | 200 | ||
52-Week Range ($) | 0.00006 - 0.0003 | ||
Shares Outstanding (Mil) | 49.35 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arno Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arno Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Arno Therapeutics Inc Frequently Asked Questions
What is Arno Therapeutics Inc(ARNI)'s stock price today?
The current price of ARNI is $0.00. The 52 week high of ARNI is $0.00 and 52 week low is $0.00.
When is next earnings date of Arno Therapeutics Inc(ARNI)?
The next earnings date of Arno Therapeutics Inc(ARNI) is .
Does Arno Therapeutics Inc(ARNI) pay dividends? If so, how much?
Arno Therapeutics Inc(ARNI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |